Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension

Chest

Volumn 150, Issue 1, 2016, Pages 57-67

  Hasler, Elisabeth D ^a   Müller Mottet, Séverine ^a   Furian, Michael ^a   Saxer, Stéphanie ^a   Huber, Lars C ^a   Maggiorini, Marco ^a   Speich, Rudolf ^a   Bloch, Konrad E ^a,b   Ulrich, Silvia ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

chronic thromboembolic pulmonary hypertension; exercise; hemodynamics; pulmonary arterial hypertension; pulmonary hypertension

Indexed keywords

ADULT; AGED; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; EXERCISE; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART INDEX; HUMAN; LIMIT OF QUANTITATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXYGEN SATURATION; PREDICTIVE VALUE; PRIORITY JOURNAL; SURVIVAL RATE; SWAN GANZ CATHETER; TRANSPLANT FREE SURVIVAL; TREATMENT OUTCOME; WALKING; COMPLICATION; EXERCISE TEST; EXERCISE TOLERANCE; HYPERTENSION, PULMONARY; LUNG EMBOLISM; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PROGNOSIS; SURVIVAL ANALYSIS; SWITZERLAND; VASCULAR RESISTANCE;

AGED; CARDIAC CATHETERIZATION; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY EMBOLISM; SURVIVAL ANALYSIS; SWITZERLAND; VASCULAR RESISTANCE;

EID: 84990046577     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1016/j.chest.2016.02.634     Document Type: Conference Paper

References (39)

1. 1 Galie, N., Humbert, M., Vachiery, J.L., et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37:1 (2016), 67–119.
2. 2 Simonneau, G., Gatzoulis, M.A., Adatia, I., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62:suppl 25 (2013), D34–D41.
3. 3 Kim, N.H., Delcroix, M., Jenkins, D.P., et al. Chronic thromboembolic pulmonary hypertension. J Am Coll Cardiol 62:suppl 25 (2013), D92–D99.
4. 4 Ulrich, S., Fischler, M., Speich, R., Popov, V., Maggiorini, M., Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties. Chest 130:3 (2006), 841–846.
5. 5 Cenedese, E., Speich, R., Dorschner, L., et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 28:4 (2006), 808–815.
6. 6 Cima, K., Twiss, J., Speich, R., et al. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). Health Qual Life Outcomes, 10(1), 2012, 110.
7. 7 Vonk-Noordegraaf, A., Haddad, F., Chin, K.M., et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol 62:suppl 25 (2013), D22–D33.
8. 8 Blumberg, F.C., Arzt, M., Lange, T., Schroll, S., Pfeifer, M., Wensel, R., Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension. Eur J Heart Fail 15:7 (2013), 771–775.
9. 9 Chaouat, A., Sitbon, O., Mercy, M., et al. Prognostic value of exercise pulmonary haemodynamics in pulmonary arterial hypertension. Eur Respir J 44:3 (2014), 704–713.
10. 10 Fischler, M., Speich, R., Dorschner, L., et al. Pulmonary hypertension in Switzerland: treatment and clinical course. Swiss Med Wkly 138:25-26 (2008), 371–378.
11. 11 Benza, R.L., Gomberg-Maitland, M., Miller, D.P., et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 141:2 (2012), 354–362.
12. 12 Mueller-Mottet, S., Stricker, H., Domeninghetti, G., et al. Long-term data from the Swiss pulmonary hypertension registry. Respiration 89:2 (2015), 127–140.
13. 13 Swiston, J.R., Johnson, S.R., Granton, J.T., Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med 104:11 (2010), 1588–1607.
14. 14 Galie, N., Barbera, J.A., Frost, A.E., et al. Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension. N Engl J Med 373:9 (2015), 834–844.
15. 15 Pulido, T., Adzerikho, I., Channick, R.N., et al. Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 369:9 (2013), 809–818.
16. 16 Wensel, R., Opitz, C.F., Anker, S.D., et al. Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing. Circulation 106:3 (2002), 319–324.
17. 17 Grunig, E., Tiede, H., Enyimayew, E.O., et al. Assessment and prognostic relevance of right ventricular contractile reserve in patients with severe pulmonary hypertension. Circulation 128:18 (2013), 2005–2015.
18. 18 Wensel, R., Francis, D.P., Meyer, F.J., et al. Incremental prognostic value of cardiopulmonary exercise testing and resting haemodynamics in pulmonary arterial hypertension. Int J Cardiol 167:4 (2013), 1193–1198.
19. 19 Bossone, E., Naeije, R., Exercise-induced pulmonary hypertension. Heart Failure Clinics 8:3 (2012), 485–495.
20. 20 Lewis, G.D., Bossone, E., Naeije, R., et al. Pulmonary vascular hemodynamic response to exercise in cardiopulmonary diseases. Circulation 128:13 (2013), 1470–1479.
21. 21 Grunig, E., Weissmann, S., Ehlken, N., et al. Stress Doppler echocardiography in relatives of patients with idiopathic and familial pulmonary arterial hypertension: results of a multicenter European analysis of pulmonary artery pressure response to exercise and hypoxia. Circulation 119:13 (2009), 1747–1757.
22. 22 Herve, P., Lau, E.M., Sitbon, O., et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur Respir J 46:3 (2015), 728–737.
23. 23 Badesch, D.B., Champion, H.C., Sanchez, M.A., et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 54:suppl 1 (2009), S55–S66.
24. 24 Kovacs, G., Avian, A., Olschewski, A., Olschewski, H., Zero reference level for right heart catheterisation. Eur Respir J 42:6 (2013), 1586–1594.
25. 25 Kovacs, G., Avian, A., Pienn, M., Naeije, R., Olschewski, H., Reading pulmonary vascular pressure tracings. How to handle the problems of zero leveling and respiratory swings. Am J Respir Crit Care Med 190:3 (2014), 252–257.
26. 26 Ryan, J.J., Rich, J.D., Thiruvoipati, T., Swamy, R., Kim, G.H., Rich, S., Current practice for determining pulmonary capillary wedge pressure predisposes to serious errors in the classification of patients with pulmonary hypertension. Am Heart J 163:4 (2012), 589–594.
27. 27 Naeije, R., Vanderpool, R., Dhakal, B.P., et al. Exercise-induced pulmonary hypertension: physiological basis and methodological concerns. Am J Respir Crit Care Med 187:6 (2013), 576–583.
28. 28 Linehan, J.H., Haworth, S.T., Nelin, L.D., Krenz, G.S., Dawson, C.A., A simple distensible vessel model for interpreting pulmonary vascular pressure-flow curves. J Applied Physiol 73:3 (1992), 987–994.
29. 29 Blumberg, F.C., Riegger, G.A., Pfeifer, M., Hemodynamic effects of aerosolized iloprost in pulmonary hypertension at rest and during exercise. Chest 121:5 (2002), 1566–1571.
30. 30 Castelain, V., Chemla, D., Humbert, M., et al. Pulmonary artery pressure-flow relations after prostacyclin in primary pulmonary hypertension. Am J Respir Crit Care Med 165:3 (2002), 338–340.
31. 31 Naeije, R., Chesler, N., Pulmonary circulation at exercise. Compr Physiol 2:1 (2012), 711–741.
32. 32 Kovacs, G., Berghold, A., Scheidl, S., Olschewski, H., Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J 34:4 (2009), 888–894.
33. 33 Janicki, J.S., Weber, K.T., Likoff, M.J., Fishman, A.P., The pressure-flow response of the pulmonary circulation in patients with heart failure and pulmonary vascular disease. Circulation 72:6 (1985), 1270–1278.
34. 34 Kafi, S.A., Melot, C., Vachiery, J.L., Brimioulle, S., Naeije, R., Partitioning of pulmonary vascular resistance in primary pulmonary hypertension. J Am Coll Cardiol 31:6 (1998), 1372–1376.
35. 35 Kovacs, G., Olschewski, A., Berghold, A., Olschewski, H., Pulmonary vascular resistances during exercise in normal subjects: a systematic review. Eur Respir J 39:2 (2012), 319–328.
36. 36 Reeves, J.T., Linehan, J.H., Stenmark, K.R., Distensibility of the normal human lung circulation during exercise. Am J Physiol Lung Cell Mol Physiol 288:3 (2005), L419–L425.
37. 37 Lau, E.M., Chemla, D., Godinas, L., et al. Loss of vascular distensibility during exercise is an early hemodynamic marker of pulmonary vascular disease. Chest 149:2 (2016), 353–361.
38. 38 Provencher, S., Herve, P., Sitbon, O., Humbert, M., Simonneau, G., Chemla, D., Changes in exercise haemodynamics during treatment in pulmonary arterial hypertension. Eur Respir J 32:2 (2008), 393–398.
39. 39 Keusch, S., Bucher, A., Muller-Mottet, S., et al. Experience with exercise right heart catheterization in the diagnosis of pulmonary hypertension: a retrospective study. Multidiscip Respir Med, 19(1), 2014, 51.